6470B Triple quadrupole LC/MS
The Agilent 6470B triple quadrupole LC/MS system delivers robust performance and high versatility for commercial, life sciences research, and regulatory applications.Request a quote
The Agilent 6470B triple quadrupole LC/MS system delivers robust performance and high versatility for commercial, life sciences research, and regulatory applications. Through a large choice of ion sources, your lab can confidently tackle any type of analysis demands. With best-in-class sensitivity, precision, and scan speed, you can afford to use less or diluted sample amounts and still be highly confident in the accuracy of your results.
The 6470B LC/MS/MS triple quadrupole employs multiple technological advantages like the Agilent Jet Stream ion source, curved geometry collision cell, and ±20 kV high energy dynode. These innovations enable you to maximize ionization, minimize instrument downtime, and reach extremely low limits of detection, while achieving wide linear dynamic range. With the addition of VacShield enhancing the system’s proven robustness and reliability, your lab will spend less time on maintenance and gain more uninterrupted productivity.
- Reduced maintenance time with VacShield technology allows you to carry out ion injector capillary maintenance without venting
- Maximized ion formation reaches detection limits up to the sub-femtogram level with Agilent Jet Stream (AJS) source
- Multiple versatile and easy-to-configure ion sources allow you to tackle any type of LC/MS analysis (AJS, ESI, APCI, and MMI)
- Wide mass range allows the analysis of ions of various classes and sizes (small molecules to multiply charged peptides)
- Screen, confirm, and quantify with triggered MRM (tMRM), which combines fast and sensitive MRM quantitation with the generation of a product ion spectrum for library searching and compound screening and confirmation
- Built-in technical controls combined with procedural controls ensure the security of your data, control access, and facilitate compliance as defined by US FDA 21 CFR Part 11, EU Annex 11 and similar national electronic record regulations